Navigation Links
Star Scientific Files Second Quarter Financial Results; Rock Creek Pharmaceuticals Reports Early Promising Results in Studies Assessing Safety and Viability of Active Components for a Non-Nicotine Nutraceutical (CigRx(TM))
Date:8/10/2009

l(R). If an agreement is achieved, Star anticipates it will be able to achieve both cost reductions and broadened product distribution for its dissolvable tobacco products.

Second quarter R&D expenses also included expenditures of $.4 million by the company's Rock Creek Pharmaceuticals subsidiary. These expenditures related to assessing the applicability of low-TSNA tobacco and certain MAO agents for several applications, including in a non-nicotine nutraceutical product designed to minimize nicotine cravings.

Rock Creek now has completed two preliminary studies to assess the viability and safety of the active components for a non-nicotine nutraceutical (a dietary supplement product). Curtis Wright, MD, MPH, Chief Medical Officer of Rock Creek, stated he is pleased with the preliminary results of the safety studies now being conducted at two independent research institutions. "There is increasing evidence in recent years that the association between nicotine addiction and MAO reduction in smokers is important. It is one thing to read research reports and publications but it is quite another to see primary data showing that tobacco can decrease human MAO B to levels similar to those seen in strong antidepressants." Rock Creek's research program is central to its evolving strategies and to the continued development of products for the treatment of cigarette addiction, including a non-nicotine nutraceutical that would be marketed under the brand name CigRx(TM). At the same time Star continues its efforts to identify a pharmaceutical or health-related entity that could assist in the distribution and consumer acceptance of a nutraceutical product such as CigRx(TM).

General and administrative expenses for the second quarter, which totaled approximately $5.1 million, included $2.7 million of increased legal expenses for the jury trial referenced above and the ongoing patent reexamination process before t
'/>"/>

SOURCE Star Scientific, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. iPierian Appoints Dr. Chad Cowan and Dr. Konrad Hochedlinger to Scientific Advisory Board
2. Boston Scientific to Participate in BMO Capital Markets Health Care Conference
3. Professor Bruce Beutler Joins aTyr Pharmas Scientific Advisory Board
4. ULURU Inc. to Present Altrazeal(TM) Clinical Evidence at the American Podiatric Medical Association (APMA) Annual Scientific Meeting in Toronto, Canada
5. Boston Scientific Announces Election of Katharine Bartlett and Bruce Byrnes to Its Board of Directors
6. Patriot Scientific Corporation Announces Cardiac Science Corporations Purchase of a Moore Microprocessor Patent(TM) Portfolio License
7. American Academy of Dermatology to Hold Summer Scientific Meeting in Boston
8. Ethicon Endo-Surgery Holds Metabolic Surgery Scientific Forum Featuring Research By Top Scientists
9. Boston Scientific Announces Results for Second Quarter Ended June 30, 2009
10. Shifting Scientific, Health Priorities and Global Economic Downturn Impact Investment in HIV Prevention R&D
11. FDA Approves Boston Scientifics TAXUS(R) Liberte(R) Long Stent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... ... July 29, 2015 , ... Potomac Pilates, an elite Washington, D.C. metro ... Rock the Reformer ® by Potomac Pilates. On Thursday, July 30, Potomac Pilates ... Reformer ® by Potomac Pilates will continue to offer the same classes and personal ...
(Date:7/29/2015)... ... July 29, 2015 , ... Ticket Down is a ... Brazil vs. USA . , The international soccer schedule of matches ... exponentially and now on September 8th, one of the world’s greatest teams, Brazil, will ...
(Date:7/29/2015)... ... , ... This year, the threat of flooding is higher in many areas ... water, mold is not far behind. Paul Davis, a leading provider of property restoration ... damage. Paul Davis is regularly called on to handle these types of emergencies, although ...
(Date:7/29/2015)... ... July 29, 2015 , ... San Fernando Valley ... Ultherapy. For a limited time only, patients can get the complete treatment process with ... patients who prefer a non-invasive treatment and have loose or sagging skin. , ...
(Date:7/29/2015)... Los Angeles, CA (PRWEB) , ... July 29, 2015 , ... We are privileged to ... at Keck Medicine of USC as the ninth best ophthalmology hospital in the nation for ... the top 10 American hospitals for ophthalmology. , “It is an honor to be ...
Breaking Medicine News(10 mins):Health News:Same Great Pilates Studio, New Brand - Rock the Reformer 2Health News:Cheap USA vs. Brazil Tickets at Gillette Stadium: Ticket Down Cuts Presale Ticket Prices for Brazil vs. USA Men's National Soccer Team (USMNT) at Gillette Stadium 2Health News:Cheap USA vs. Brazil Tickets at Gillette Stadium: Ticket Down Cuts Presale Ticket Prices for Brazil vs. USA Men's National Soccer Team (USMNT) at Gillette Stadium 3Health News:Paul Davis Offers Tips to Minimize Property Damage and Health Risks This Flood Season 2Health News:Paul Davis Offers Tips to Minimize Property Damage and Health Risks This Flood Season 3Health News:San Fernando Valley Dermatology Office, Castle Dermatology Institute, is Now Offering a Promotional Price on Ultherapy 2Health News:21 Years & Counting: The USC Eye Institute Ranks in the Top 10 Ophthalmology Hospitals in America 2Health News:21 Years & Counting: The USC Eye Institute Ranks in the Top 10 Ophthalmology Hospitals in America 3
... Media have less than three weeks to register ... Multidisciplinary Cancer Congress in Stockholm, 23-27 September 2011. ... European Multidisciplinary Cancer Congress will take place at ... www.stofair.se ) from Friday 23 September to Tuesday ...
... A genomic study of chronic blood cancer - a precursor ... diagnosis using only a blood test, avoiding the need for ... the Wellcome Trust Sanger Institute identified the SF3B1 gene as ... forms of blood cancer. Myelodysplasia is particularly prevalent among people ...
... MONDAY, Sept. 26 (HealthDay News) -- People with heart disease ... return to a normal rate after exercise, a new study ... with normal heart rate recovery live longer than those whose ... "There,s no medicine that can do that," study author ...
... University professor is leading research efforts to develop new ... a neurodegenerative disorder that affects nearly six million people ... diagnosed in the United States alone each year. ... rigid muscles, difficulty initiating movement, speech changes, postural instability ...
... The Autism Speaks Autism Treatment Network (ATN), has received ... as the Autism Intervention Research Network on Physical Health ... guidelines, tool kits for families and physicians, and clinician ... a jump start in developing the kinds of research ...
... released this week, challenges people to test their knowledge ... they learn about the complexities of the disease, which ... Californians. Developed as a free download by the ... and QuantiaMD, a company headquartered in Waltham, Massachusetts, the ...
Cached Medicine News:Health News:Media have less than 3 weeks to register for the European Multidisciplinary Cancer Congress 2011 2Health News:Media have less than 3 weeks to register for the European Multidisciplinary Cancer Congress 2011 3Health News:Researchers uncover gene associated with blood cancers 2Health News:Researchers uncover gene associated with blood cancers 3Health News:Cardiac Rehab May Help Heart Patients Live Longer 2Health News:Wayne State researcher developing treatments for Parkinson's with aid of $2.15 million NIH grant 2Health News:Autism Speaks Autism Treatment Network receives $12 million AIR-P grant 2Health News:Interactive mobile app from UCSF and QuantiaMD teaches people how to manage diabetes 2Health News:Interactive mobile app from UCSF and QuantiaMD teaches people how to manage diabetes 3
(Date:7/29/2015)... Surgical Company (NASDAQ: STAA ), a leading developer, manufacturer ... eye today reported financial results for the second quarter ended ... , Net Sales of $18.7 Million Down 7% from the ... Million from the Weakening Euro and Yen , ICL ... , APAC Sales Down 1% Including Korea - Up 16% ...
(Date:7/29/2015)... ALTO, Calif. , July 29, 2015 ... it has, through one of its European subsidiaries, agreed ... -based supplier of components and subsystems for X-ray imaging ... will pay approximately €50 million in cash for ... August. Claymount is one of the ...
(Date:7/29/2015)... 2015  Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA ... second quarter ended June 30, 2015. "We ... and Fanapt" said Mihael H. Polymeropoulos M.D., Vanda,s President ... cycle management of our products set the stage for ... Financial Highlights , Total net product sales ...
Breaking Medicine Technology:STAAR Surgical Reports Second Quarter 2015 Results 2STAAR Surgical Reports Second Quarter 2015 Results 3STAAR Surgical Reports Second Quarter 2015 Results 4STAAR Surgical Reports Second Quarter 2015 Results 5STAAR Surgical Reports Second Quarter 2015 Results 6STAAR Surgical Reports Second Quarter 2015 Results 7STAAR Surgical Reports Second Quarter 2015 Results 8STAAR Surgical Reports Second Quarter 2015 Results 9STAAR Surgical Reports Second Quarter 2015 Results 10STAAR Surgical Reports Second Quarter 2015 Results 11STAAR Surgical Reports Second Quarter 2015 Results 12STAAR Surgical Reports Second Quarter 2015 Results 13STAAR Surgical Reports Second Quarter 2015 Results 14STAAR Surgical Reports Second Quarter 2015 Results 15STAAR Surgical Reports Second Quarter 2015 Results 16STAAR Surgical Reports Second Quarter 2015 Results 17STAAR Surgical Reports Second Quarter 2015 Results 18STAAR Surgical Reports Second Quarter 2015 Results 19STAAR Surgical Reports Second Quarter 2015 Results 20STAAR Surgical Reports Second Quarter 2015 Results 21STAAR Surgical Reports Second Quarter 2015 Results 22STAAR Surgical Reports Second Quarter 2015 Results 23STAAR Surgical Reports Second Quarter 2015 Results 24Varian Medical Systems Acquiring Claymount to Expand Imaging Components Portfolio 2Varian Medical Systems Acquiring Claymount to Expand Imaging Components Portfolio 3Varian Medical Systems Acquiring Claymount to Expand Imaging Components Portfolio 4Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 2Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 3Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 4Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 5Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 6Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 7Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 8Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 9Vanda Pharmaceuticals Reports Second Quarter 2015 Financial Results 10
... TetraLogic Pharmaceuticals , a biopharmaceutical company developing novel small ... the oral presentation of new data on its Smac ... Meeting and Exposition in San Diego. The study, conducted ... Center, demonstrated that TL32711 induces apoptosis in acute myeloid ...
... Dec. 10, 2011  A group of Penn Medicine researchers is ... they,re challenging the public to help. The MyHeartMap Challenge, a ... will send thousands of Philadelphians to the streets and to ... (AEDs) as they can. The contest is just a first ...
Cached Medicine Technology:TetraLogic Pharmaceuticals Announces Oral Presentation on Smac Mimetic TL32711 at American Society of Hematology (ASH) Annual Meeting 2Penn Medicine Contest Challenges Philadelphians to Help Save Lives With Their Cell Phones 2Penn Medicine Contest Challenges Philadelphians to Help Save Lives With Their Cell Phones 3Penn Medicine Contest Challenges Philadelphians to Help Save Lives With Their Cell Phones 4
... Thermovent® T helps provide protection to the exposed ... and extremely lightweight making it ideal for active ... high rate of heat and moisture recovery, it ... ,All HMEs and filters have ISO standard tapered ...
circuitGuard™ Products are available in filter or filter/HME styles., ,High quality air cushion anesthesia masks may be packaged with any circuitGuard™ product....
... Since 1991 Intersurgical Incorporated ... filters, heat and moisture ... therapy products, hand-held nebulizers ... of accessories and connectors ...
... Intersurgical Incorporated manufactures high ... and moisture exchangers, ventilator ... hand-held nebulizers and an ... and connectors for anesthesia ...
Medicine Products: